Neurological & Psychological Disorders

News on research and diagnostic developments in neuroscience.

The firm has licensed its test to Abbott, BioMérieux, and Quanterix, and it is working with the US Department of Defense as part of a collaborative approach.

The court's determination is critical to deciding if Williams v Quest/Athena can advance or if it must be dismissed on statute of repose grounds. 

The test from Banyan Biomarkers called the Brain Trauma Indicator measures the levels of the proteins UCH-L1 and GFAP that are released into the blood.

Three independent studies have shown that an α-synuclein assay technology detected early Parkinson's with high levels of sensitivity and specificity.

Irish rare disease research center FutureNeuro is partnering with software vendor Congenica to bring sequencing to the point of care for genetic epilepsies.